首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1463332

全球生物標記市場規模、佔有率、成長分析、依類型（安全性、功效）、依應用（診斷、藥物發現和開發）、依疾病（癌症、心血管疾病）- 2024-2031 年行業預測

Global Biomarkers Market Size, Share, Growth Analysis, By Type(Safety, Efficacy), By Application(Diagnostics, Drug discovery & development), By Disease(Cancer, Cardiovascular Diseases) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球生物標記市場規模為669.7億美元，預計將從2023年的758.8億美元成長到2031年的2060.4億美元，在預測期內（2024-2031年）複合年成長率為13.3%。

該公司的成長預計將受到多種因素的推動，例如伴隨診斷的重要性日益增強、癌症發病率上升、生物標記研究資金增加以及持續研究取得的重大發現。例如，2022年10月，波士頓大學的研究人員從美國國立衛生研究院獲得了460萬美元的資金，用於創建肺癌的新生物標記。透過技術進步開發基於生物標記的診斷是推動市場擴張的另一個因素。研究能夠開發出有效的藥物來治療多種疾病，例如癌症、心血管、免疫和神經系統疾病。它還有助於了解如何儘早避免和發現某種疾病。據觀察，該部門的公共和私人投資均增加。例如，2022 年 3 月，Quanterix Corp. 宣布阿茲海默症藥物發現基金會已提供資金，以加快創建阿茲海默症診斷血漿測試。在臨床環境中使用基於血漿的生物標記來診斷阿茲海默症的日子很快就要到來。例如，根據2021 年微生物學前沿報道，已經發現了潛在的基於MicroRNA 的生物標記物，可用於檢測鼻病毒、流感感染、結核病、愛滋病毒、瘧疾、伊波拉病毒和亨德拉病毒等疾病。這些基於miRNA 的標記物的目標是為了幫助及早發現傳染病。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
QIAGEN NV
Bio-Rad Laboratories, Inc.
Merck & Co., Inc.
PerkinElmer, Inc.
Illumina, Inc.
BD (Becton, Dickinson and Company)
Myriad Genetics, Inc.
Siemens Healthineers AG
Danaher Corporation
Biomerieux SA
Waters Corporation
Abbott Laboratories
Sysmex Corporation
Bio-Techne Corporation
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Pacific Biomarkers, Inc.

簡介目錄

Product Code: SQMIG35A2509

Global Biomarkers Market size was valued at USD 66.97 billion in 2022 and is poised to grow from USD 75.88 billion in 2023 to USD 206.04 billion by 2031, growing at a CAGR of 13.3% during the forecast period (2024-2031).

The company's growth is expected to be fueled by a number of factors, such as the growing significance of companion diagnostics, the rising incidence of cancer, increased financing for biomarker research, and significant discoveries made as a result of continuing research. For example, in October 2022, researchers at Boston University received USD 4.6 million in funding from the National Institutes of Health to create new biomarkers for lung cancer. The development of biomarker-based diagnostics through technical advancement is another factor driving market expansion. Research enables the development of effective medications to treat a wide range of ailments, such as cancer, cardiovascular, immunological, and neurological conditions. It also helps in understanding how to avoid and detect a certain disease early on. It has been observed that both public and private investment in the sector has increased. For example, in March 2022, Quanterix Corp. announced that funding had been provided by the Alzheimer's Drug Discovery Foundation to expedite the creation of a diagnostic plasma test for Alzheimer's disease. The use of plasma-based biomarkers in clinical settings to diagnose Alzheimer's disease is quickly approaching.In the upcoming years, it is projected that the use of biomarkers in the diagnosis of infectious diseases would increase significantly. For example, potential MicroRNA-based biomarkers for the detection of diseases like rhinoviruses, influenza infections, tuberculosis, HIV, malaria, Ebola, and Hendra virus have been discovered, according to Frontiers in Microbiology in 2021. The goal of these miRNA-based markers is to help detect infectious diseases early on.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarkers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarkers Market Segmental Analysis

The global biomarkers market is segmented based on type, application, disease, and region. In terms of type, the market is classified into safety, efficacy, and validation. With respect to application, the market is categorized into diagnostics, drug discovery & development, personalized medicine, and others. In terms of disease, the market is segmented into cancer, cardiovascular diseases, neurological diseases, and immunological diseases. Regionwise, the global biomarkers market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Biomarkers Market

Because customized medicine enables more individualized and successful patient care, its demand is rising. Because they can be used to identify patient-specific biological signals that can inform treatment decisions, biomarkers are essential to personalized medicine.

Restraints in the Global Biomarkers Market

The process of finding and developing biomarkers is not standardized, which might cause variations in the accuracy and dependability of biomarker tests. This may make it more difficult for biomarkers to be used in clinical settings and may also cause problems with regulations.

Market Trends of the Global Biomarkers Market

Tests called companion diagnostics are intended to find biomarkers that suggest whether or not a patient may benefit from a specific treatment. The significance of these tests in personalized medicine and drug development is growing. Because of this, the companion diagnostics industry is expanding quickly, and numerous pharmaceutical companies are collaborating with diagnostic companies to create and promote these tests.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Biomarkers Market by Type

Market Overview
Safety
Efficacy
and Validation

Global Biomarkers Market by Application

Market Overview
Diagnostics
Drug discovery & development
Personalized Medicine
and Others

Global Biomarkers Market by Disease

Market Overview
Cancer
Cardiovascular Diseases
Neurological Diseases
and Immunological Diseases

Global Biomarkers Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biomarkers, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments